The Chinese consumer market is reeling after a multi-departmental investigation was launched into the safety of the nation’s infant diaper industry. On June 22, four of China’s most powerful regulatory bodies—including the State Administration for Market Regulation and the National Health Commission—announced a joint probe into the presence of formamide in prominent diaper brands. This swift state intervention follows a week of explosive media reports and public denials that have rattled parents across the country.
The controversy began with an investigative report by the Xinhua-affiliated Economic Information Daily, which claimed that popular brands such as Huggies, Babycare, and Biba contained formamide. A reproductive toxin banned in cosmetics in China and classified as a 1B reproductive hazard in the EU, formamide is known to cause chronic damage to the liver and kidneys. The report featured a journalist who claimed his own blood formamide levels spiked significantly after wearing a diaper overnight, a dramatic demonstration that has fueled public anxiety.
What followed was a series of chaotic reversals that underscore the volatile relationship between Chinese media and the manufacturing sector. After an initial denial from a medical center and an industry association, the reporting journalist released audio evidence suggesting that medical experts had been pressured by their institutions to retract their findings. While the brands involved have since released independent laboratory reports showing no detectable levels of the toxin, the government’s decision to step in suggests that private assurances are no longer sufficient to maintain social stability.
This scandal strikes at a time when China’s diaper industry is struggling with the economic realities of a demographic downturn. With market growth slowing to a mere 3.7% annually, the sector has devolved into a zero-sum game defined by aggressive price wars and thinning margins. Financial reports from domestic leaders like Haoyue Nursing and Biary illustrate this decline, showing significant drops in net profit as production costs rise and consumer demand stagnates.
Industry analysts view this investigation as a potential watershed moment that could force a consolidation of the market. Historically, Chinese consumer sectors have seen similar 'rebranding through regulation' after safety scares, where smaller, less compliant players are purged in favor of high-standard national champions. For the remaining players, the competition is likely to shift from predatory pricing to a high-stakes 'value war' centered on transparency, material science, and verified safety standards.